Acer macrophyllum
Acer macrophyllum · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Acer macrophyllum, commonly known as the bigleaf maple, is a majestic tree that holds significant potential in the realm of botanical medicine. Research into its leaves suggests they may contain bioactive compounds useful in addressing complex ocular health issues. Specifically, these extracts are being studied for their ability to assist with conditions such as Dry Eye Disease and retinal degeneration. Furthermore, the plant demonstrates unique properties related to hemostasis, which could play a role in managing vascular stability. Understanding these medicinal properties offers a promising pathway for developing new therapeutic interventions for vision preservation.
- Synonyms
- Acer Macrophyllum F. Tricolor · Acer Macrophyllum F. Angustialatum · 18 more
- Common names
- Not available
- Family
- Sapindaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Common Names
Acer macrophyllum is widely recognized by its English common name, the Bigleaf Maple. This impressive species is also known by various international names, such as the Oregon-Ahorn in German. In other languages, it carries distinct titles like the Grootbladige esdoorn in Afrikaans or the Großblättriger Ahorn in German. Furthermore, the plant is identified as the Klon wielkolistny in Polish. These diverse names reflect the global recognition of this unique maple across different linguistic cultures.
Sources: Catalogue of Life (COL)
Synonyms
Acer macrophyllum is a complex species that has been identified by various botanical names throughout history. Scientific literature frequently lists several synonyms for this plant, including the designation Acer auritum. Researchers have also encountered it under the names Acer coptophyllum and Acer dactylophyllum. Furthermore, the plant is sometimes referred to as Acer hemionitis in different taxonomic contexts. Finally, the synonym Acer leptodactylon serves as another historical label associated with this specific maple.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Acer macrophyllum belongs to the vast kingdom Plantae, representing the diverse world of multicellular organisms. Within this realm, it is classified under the class Equisetopsida, marking its place among the vascular plants. This species is further organized into the order Sapindales, a group that shares specific evolutionary traits. It is a prominent member of the family Sapindaceae, which links it to a variety of other unique flowering plants. Ultimately, this Bigleaf maple is defined by its membership in the genus Acer, a lineage renowned for its distinct leaf structures.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Sapindales |
| Family | Sapindaceae |
| Genus | Acer |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Acer macrophyllum is a widespread species native to the vast landscapes of Northern America. Its presence is particularly dominant throughout the lush coastal regions of British Columbia in Western Canada. Moving southward, the tree thrives across the Pacific Northwest, spanning the diverse terrains of both Washington and Oregon. The distribution continues deep into the Southwestern United States, where it is a common sight in California. This extensive range highlights the plant's remarkable ability to adapt to various western ecological niches.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Acer macrophyllum is a self-supporting tree that commands attention in its natural habitat. This robust species exhibits a massive growth form, reaching impressive heights of at least 23.935 meters. Such stature allows it to stand prominently within the forest canopy.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Acer macrophyllum, specifically through its use as a herbal medicine, is known to treat hemostasis and various hepatic disorders. Research indicates that its extracts can effectively treat N-ethyl-N-nitrosourea (ENU)-induced retinal degeneration by modulating protein expression and protecting the retinal layers. Furthermore, the plant provides therapeutic benefits for dry eye disease by suppressing inflammation on the ocular surface. It also acts to treat hyperosmolar stress (HOS)-induced human corneal epithelial cells (HCECs) through anti-inflammatory and anti-apoptotic mechanisms. These diverse applications highlight the plant's significant medicinal potential in addressing both systemic and ocular health issues.
Preparations
Parts used
Acer macrophyllum is a species that possesses specialized leaf structures which can be utilized for therapeutic research. While the provided study focuses on the medicinal properties of maple leaf extracts, it highlights how botanical components serve as vital sources for biochemical study. Specifically, extracts derived from these leaves have demonstrated significant anti-inflammatory and anti-apoptotic effects in cellular models. By suppressing the production of pro-inflammatory mediators, such extracts may offer protection against ocular surface diseases. This research underscores the profound biological potential held within the various parts of the maple plant.